Why the CEO of Sean Parker’s cancer institute left to help the ‘cellular police’ arrest diseases like diabetes

San Francisco Business Times

Why the CEO of Sean Parker’s cancer institute left to help the ‘cellular police’ arrest diseases like diabetes

Cell therapy pioneer Jeff Bluestone is launching a new biotech company with $40 million in venture funding, aiming to corral the power of a special type of cell that could shut down inflammatory autoimmune diseases.

The 12-employee South San Francisco company, called Sonoma Biotherapeutics Inc., includes superstar founders, staff, board and investors, starting with Bluestone, who spent the past four-plus years as president and CEO of billionaire Sean Parker’s San Francisco-based cancer immunotherapy institute….